PTPRC and nonpapillary renal cell carcinoma: In summary, PBNK from ccRCC patients display an inhibitory profile characterized by overexpression of CD85j, CD45, CD48 and PD-1, while TINK exhibit additional alterations characterized by a decreased expression of several activating receptors.